The company appealed against refusal of patentunder the provision restricting such for ‘uses of human embryos for industrial or commercial purposes’
Held: The matter was referred to the ECJ.
Henry Carr QC
[2013] EWHC 807 (Ch), [2013] 3 CMLR 14, [2014] RPC 2, BL O/316/12, [2013] 3 CMLR 14, [2014] RPC 2
Bailii
Patents Act 1977
England and Wales
Citing:
Appeal from – International Stem Cell Corporation (Patent) IPO 16-Aug-2012
IPO Patent applications GB0621068.6 and GB0621069.4 relate to methods where parthenogenesis is used to activate a human oocyte (i.e. stimulation of a human oocyte, without fertilisation by a sperm cell) to . .
Cited by:
Reference – International Stem Cell Corporation v Comptroller General of Patents ECJ 17-Jul-2014
ECJ (Advocate General’s Opinion) – Directive 98/44/EC – Legal protection of biotechnological inventions – Patentability – Stem cells – Stimulation by parthenogenesis of unfertilised human ova to create stem cells . .
Reference – International Stem Cell Corporation v Comptroller General of Patents ECJ 18-Dec-2014
ECJ Grand Chamber – Reference for a preliminary ruling – Directive 98/44/EC – Article 6(2)(c) – Legal protection of biotechnological inventions – Parthenogenetic activation of oocytes – Production of human . .
Lists of cited by and citing cases may be incomplete.
Intellectual Property
Updated: 20 January 2022; Ref: scu.472647
